KORSANA BIOSCIENCES
Live / Allowed — First extension granted (statement of use) (as of 16 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99442001
- Mark type
- Word mark
- Filed
- 14 Oct 2025
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Nicole Kinsley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological and neurodegenerative diseases and disorders; Antibodies for therapeutic purposes; House mark for pharmaceuticals for the treatment of neurological and neurodegenerative diseases and disorders
Owner
- Korsana Biosciences, Inc., Waltham, MA, US
- Korsana Biosciences, Inc., Waltham, MA, US
Prosecution history
- 17 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jun 2026 — SOU EXTENSION 1 GRANTED
- 16 Jun 2026 — SOU EXTENSION 1 FILED
- 16 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Apr 2026 — PUBLISHED FOR OPPOSITION
- 08 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 17 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 17 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 03 Mar 2026 — ASSIGNED TO EXAMINER
- 14 Oct 2025 — APPLICATION FILING RECEIPT MAILED